Chemical compounds

Details for Australian Patent Application No. 2005286795 (hide)

Owner Glaxo Group Limited

Inventors Thomas, Sonia M.; Kerns, Jeffrey K.; Lin, Xichen; Nie, Hong; Lindenmuth, Michael

Agent Davies Collison Cave

Pub. Number AU-A-2005286795

PCT Pub. Number WO2006/034317

Priority 60/695,454 30.06.05 US; 60/611,761 21.09.04 US

Filing date 21 September 2005

Wipo publication date 30 March 2006

International Classifications

A61K 31/4439 (2006.01)

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/034317 Priority application(s): WO2006/034317

24 January 2008 Assignment before Grant

  Glaxo Group Limited The application has been assigned to SmithKline Beecham Corporation

14 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005286797-Porcine reproductive and respiratory syndrome isolates and methods of use

2005286793-Heterocyclic derivatives for the treatment of diseases mediated by stearoylCoA desaturase enzymes